AZN

Bispecific Antibody Drug Conjugates Market Landscape Report 2026: A $2 Billion Opportunity by 2030 with the 1st Approved BsADC by 2028 - Clinical Trials, Regulatory Approvals, Development Platforms

04/21 04:49 am

Bispecific Antibody Market Landscape Report 2026: A Potential $60 Opportunity by 2031 - Insight on More than 550 Clinical Trials - Antibody Dosage, Patent, Price, Sales & Outlook

04/21 04:34 am

Targeted Alpha Therapy Market Landscape Report 2026-2030: Clinical Trials Insights on 30 Drugs - Size, Regulatory Approvals, Proprietary Technologies, Therapeutic Applications

04/21 04:27 am

Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight

04/16 01:00 pm

Alethio Therapeutics Unveils ATX‑011, a Breakthrough, Mutation‑Agnostic Antibody for Treating Essential Thrombocythemia – a c.$2B Market, and Strengthens Leadership to Accelerate Path to IND

04/16 04:00 am

Generalized Myasthenia Gravis Market on the Brink of Change: 8 Promising Late-Stage Drugs Signal a New Treatment Era | DelveInsight

04/15 01:00 pm

AIM ImmunoTech Provides Routine Update on Annual Filings

04/13 06:00 pm

Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight

04/13 01:00 pm

$5.14 Bn Castration-sensitive Prostate Cancer Market Insights, Epidemiology, and Forecasts, 2022-2026 & 2026-2036

04/13 04:44 am

7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing Treatments

04/10 04:59 am

Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight

04/07 01:00 pm

Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight

04/06 01:00 pm

Q1 2026 Dividend Check-In: Highest Quarterly Hike Percentage Since 2019

04/02 10:36 am

Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report

04/02 04:44 am

A Healthy Return: Drug Spin-off Nets Keymed Up To $320M

04/02 04:16 am

Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight

04/01 01:00 pm

AstraZeneca Scores Pediatric Win While Adult Trial Falls Short In Rare Bone Disease

03/31 11:53 am

Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed

03/30 06:00 am

Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate

03/30 05:00 am

International ETFs: EEM and IEFA Offer Distinct Global ETF Choices

03/27 10:08 am

AstraZeneca Strengthens Position In COPD Race With Successful Trials

03/27 08:46 am

Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears

03/24 01:53 pm

2 Healthcare Stocks to Buy Before They Get Bought Out

03/20 05:34 am

Jacobio Pharma Poised To Turn A Profit From Precision Cancer Drugs

03/19 07:40 am

Pseudomonal Infections Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 10+ Leading Players Wheeling the Therapeutics Landscape

03/16 01:00 pm

Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report

03/16 07:19 am

Could This International ETF Be One of the Best Investments of 2026?

03/14 08:07 am

Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline

03/12 06:46 am

GLP-1 Receptor Agonist (Trulicity, Wegovy, Ozempic, Mounjaro) Market Trends Analysis Report 2026

03/05 11:58 am

Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

03/05 05:44 am

CDT Positions for Transformational Growth

03/04 09:30 am

GLP-1 Receptor Agonist Business Analysis Report 2026: Market to Reach $137.4 Billion by 2030 - Clinical Trials Exploring GLP-1 Role in NAFLD and NASH Unlock Future Opportunities

03/04 06:48 am

Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight

03/02 02:00 pm

Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence

03/02 05:59 am

PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race

02/26 02:35 pm

FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer

02/20 09:02 am

Glucagon-like Peptide 1 (GLP-1) Market Report 2026-2035: Market to Reach $33.26 Billion by 2030 - Oral Formulations and Long-Acting Peptides Accelerate Next-Gen Obesity and Diabetes Therapies

02/20 06:53 am

CTLA-4 Inhibitors Competitive Landscape Research Report 2026: Comprehensive Insights About 40+ Companies and 50+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type

02/18 12:00 pm

Turner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness of Rare Chromosomal Disorders – SNS Insider

02/18 06:55 am

Uterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider

02/16 09:00 am

NIH Stops Johnson & Johnson's Blood Thinner Drug Arm In Stroke Trial After Safety Review (UPDATED)

02/12 03:55 pm

AstraZeneca Cancer Portfolio Dominates Sales With Massive Double Digit Growth

02/10 01:32 pm

Anti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management

02/06 06:00 am

This Global ETF Could Help Protect You From the "Sell America" Trade

02/05 06:07 am

Obesity Treatment Market Size to Reach USD 75.69 Billion by 2033 as the Treatment Offers a Comprehensive Evaluation of Therapeutic Developments Globally

02/05 05:00 am

Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider

02/05 04:57 am

AstraZeneca Responds With Data After FDA Delays Lupus Drug Shot

02/03 07:55 am

Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica

02/03 02:56 am

AstraZeneca Expands Weight Loss Push With Eight-Program China Collaboration

01/30 08:09 am

AstraZeneca Bets Big On China With Massive $15 Billion Investment

01/29 12:51 pm